Home/Filings/4/0001179110-18-009415
4//SEC Filing

Wolff Henry Ward 4

Accession 0001179110-18-009415

CIK 0001061027other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 7:33 PM ET

Size

7.8 KB

Accession

0001179110-18-009415

Insider Transaction Report

Form 4
Period: 2018-02-28
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-06-29+6,2506,250 total
    Exercise: $2.12Exp: 2028-06-29Common Stock (6,250 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-02-28+37,50037,500 total
    Exercise: $6.80Exp: 2028-02-28Common Stock (37,500 underlying)
Footnotes (2)
  • [F1]The option shall vest and become exercisable in twenty-four (24) equal monthly installments over a two (2) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.
  • [F2]The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.

Issuer

SUNESIS PHARMACEUTICALS INC

CIK 0001061027

Entity typeother

Related Parties

1
  • filerCIK 0001302390

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 7:33 PM ET
Size
7.8 KB